Paul Noone
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 32
- Antibiotics Pharmacokinetics and Efficacy 29
-
- Antimicrobial Resistance in Staphylococcus 11
- Antifungal resistance and susceptibility 4
- Clostridium difficile and Clostridium perfringens research 4
- Co-authors
- J Pattison (8 shared papers)Richard Slack (3 shared papers)R E Pounder (2 shared papers)Andrew Kirk (1 shared paper)W.B. Grubb (1 shared paper)Penny Smith (1 shared paper)Elizabeth C. Wood (1 shared paper)Bhawna Sharma (2 shared papers)
- Journals
- The Lancet (18 papers)Journal of Antimicrobial Chemotherapy (14 papers)Journal of Clinical Pathology (9 papers)Journal of Infection (3 papers)Archives of Disease in Childhood (2 papers)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Paul Noone
67 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 116
- Molecular Medicine 277
- Applied Microbiology and Biotechnology 71
- Clinical Biochemistry 231
- Infectious Diseases 599
- Pharmacology 489
Countries citing papers authored by Paul Noone
This map shows the geographic impact of Paul Noone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Noone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Noone more than expected).
Fields of papers citing papers by Paul Noone
This network shows the impact of papers produced by Paul Noone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Noone. The network helps show where Paul Noone may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Noone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 286 | |
| 2 | 1984 | 168 | |
| 3 | 1974 | 135 | |
| 4 | 1982 | 126 | |
| 5 | 1977 | 105 | |
| 6 | 1985 | 78 | |
| 7 | 1980 | 75 | |
| 8 | 1983 | 57 | |
| 9 | 1980 | 52 | |
| 10 | 1971 | 52 | |
| 11 | 1977 | 52 | |
| 12 | 1981 | 50 | |
| 13 | 1988 | 44 | |
| 14 | 1986 | 42 | |
| 15 | 1989 | 40 | |
| 16 | 1971 | 36 | |
| 17 | 1974 | 36 | |
| 18 | The effective use of gentamicin in life-threatening sepsis. | 1974 | 35 |
| 19 | 1976 | 34 | |
| 20 | 2005 | 26 |
About Paul Noone
Paul Noone is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Molecular Medicine and Clinical Biochemistry, having authored 71 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (15 papers), Bacterial Identification and Susceptibility Testing (11 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Neutropenia and Cancer Infections (6 papers), Mycobacterium research and diagnosis (5 papers), Antifungal resistance and susceptibility (4 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). The work is most often cited by research in Molecular Medicine (277 citations), Applied Microbiology and Biotechnology (71 citations), Clinical Biochemistry (231 citations), Infectious Diseases (599 citations) and Pharmacology (489 citations). Paul Noone has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include J Pattison, Richard Slack, R E Pounder, Andrew Kirk, W.B. Grubb, Penny Smith, Elizabeth C. Wood, Bhawna Sharma, Marina Alessandra Pereira and Andrew K. Burroughs. Their work appears in journals such as The Lancet, Journal of Antimicrobial Chemotherapy, Journal of Clinical Pathology, Journal of Infection and Archives of Disease in Childhood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.